Skip to Content

Aripiprazole Injection

Last Updated: October 19, 2013
Status: Current

Products Affected - Description

Abilify 9.75 mg intramuscular injection, BMS

Reason for the Shortage

  • BMS could not provide a reason for the shortage.
  • BMS is the sole manufacturer of aripiprazole intramuscular injection.
  • This shortage does not affect Abilify oral dosage forms.

Estimated Resupply Dates

BMS has available Abilify 9.75 mg intramuscular injection (NDC 59148-0016-65).

 

Related Shortages

Updated

October 19, 2011; October 5, 2011; September 13, 2011; September 7, 2011; August 22, 2011; July 26, 2011; July 18, 2011; June 23, 2011; May 16, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide